loader from loading.io

Episode 477: A Boatload of Data on Omega-3 Benefits

Heart Doc VIP with Dr. Joel Kahn

Release Date: 01/20/2026

Episode 483: Sharing My Personal Heart Journey show art Episode 483: Sharing My Personal Heart Journey

Heart Doc VIP with Dr. Joel Kahn

This week, Dr. Kahn discusses his current health challenge: a leaky mitral valve due to mitral valve prolapse, a condition of unknown cause that is unrelated to lifestyle or diet. He reviews data on mitral valve surgery, comparing repair to replacement, as well as the current availability of robotic surgery and its advantages. He plans to keep the Heart Doc VIP community updated on his status and is feeling great day to day. Short topics this week include wine, olive oil, plant-based diets for breast cancer, Life’s Essential 8, the health of babies raised in vegan families, and new data on...

info_outline
Episode 482: Why the Framingham Heart Study Still Matters show art Episode 482: Why the Framingham Heart Study Still Matters

Heart Doc VIP with Dr. Joel Kahn

This week on Heart Doc VIP, Dr. Joel Kahn takes a deep dive into one of the most influential research projects in cardiovascular history: the Framingham Heart Study. Launched in 1948 and still going strong, this landmark study helped identify many of the risk factors we now take for granted, including smoking, diabetes, high cholesterol, high blood pressure, obesity, and physical inactivity. Much of what modern cardiology considers “common knowledge” about prevention started in Framingham. Dr. Kahn also explores practical and emerging topics in heart health, including the role of magnesium...

info_outline
Episode 481: What’s Coming Next for Lipoprotein(a) Treatments show art Episode 481: What’s Coming Next for Lipoprotein(a) Treatments

Heart Doc VIP with Dr. Joel Kahn

This week, Dr. Kahn breaks down a new paper examining the risks and reported side effects of statins—including the surprising finding that placebo alone is linked to many of the same symptoms. He also covers an oral PCSK9 inhibitor currently under study and what it could mean for cholesterol management. The episode then dives into the latest research on emerging therapies designed to lower lipoprotein(a), including a real-world case study that highlights where this rapidly evolving field is headed.  Shorter discussions include heart disease at a young age, why so many patients fail to...

info_outline
Episode 480: At What Age Do We Treat High Cholesterol? show art Episode 480: At What Age Do We Treat High Cholesterol?

Heart Doc VIP with Dr. Joel Kahn

This week, Dr. Kahn discussed a case study involving a 30-year-old man with newly discovered, very high cholesterol. The implications of heart disease in young adults—backed by a recent paper from the CARDIA study group—suggest that early intervention, beginning with lifestyle changes, should be offered, along with follow-up lab testing. The Portfolio Diet plan would be a strong starting point on the journey toward a more plant-based diet. Other topics covered include the risks of diet soda, the health impacts of being a night owl, coffee consumption for atrial fibrillation patients, the...

info_outline
Bonus Episode: TJ Robinson, the World-Famous Olive Oil Hunter show art Bonus Episode: TJ Robinson, the World-Famous Olive Oil Hunter

Heart Doc VIP with Dr. Joel Kahn

In this bonus episode, Dr. Kahn sits down with his longtime friend TJ Robinson, founder of the Fresh Pressed Olive Oil Club and self-described “olive oil hunter.” TJ has made it his life’s mission to track down the freshest, highest-quality extra virgin olive oils in the world — often straight from small producers in Europe and South America — and get them shipped to the U.S. as quickly as possible. The conversation dives into what most people don’t realize about olive oil: how freshness impacts flavor, health benefits, and antioxidant levels, and why the oil sitting on a grocery...

info_outline
Episode 478: Heart Disease in 2026 — Still the #1 Killer show art Episode 478: Heart Disease in 2026 — Still the #1 Killer

Heart Doc VIP with Dr. Joel Kahn

This week, Dr. Kahn discusses a new report from the American Heart Association on the causes of heart-related deaths in the U.S., and the sobering reality that cardiovascular disease remains the nation’s leading cause of death. Despite this, prevention and early detection continue to be underemphasized at the national level—meaning much of the responsibility still falls on individuals. Dr. Kahn also covers several shorter topics, including a response to the CSPI food pyramid, water quality on airplanes, Apple Watch detection of atrial fibrillation, why earlier meal timing is better, the...

info_outline
Episode 477: A Boatload of Data on Omega-3 Benefits show art Episode 477: A Boatload of Data on Omega-3 Benefits

Heart Doc VIP with Dr. Joel Kahn

This week, Dr. Kahn dives into four new research papers on omega-3 fatty acids and their impact on heart and brain health. The discussion highlights several eye-opening findings, including reduced atrial fibrillation risk and improved cardiovascular outcomes in patients undergoing hemodialysis. Dr. Kahn also explains how omega-3 intake supports brain health and why the “right” dose depends on the specific condition being addressed. Food sources, fish oil, algae-based supplements, and ahiflower are compared as practical ways to reach optimal omega-3 levels.  Additional topics in this...

info_outline
Episode 476: The Upside-Down Pyramid of the USDA Guidelines show art Episode 476: The Upside-Down Pyramid of the USDA Guidelines

Heart Doc VIP with Dr. Joel Kahn

This week, Dr. Kahn breaks down the newly released USDA 2025–2030 Dietary Guidelines and the surprising upside-down food pyramid they present. He explains how the final report differs from last year’s Advisory Committee recommendations, including changes in committee membership and the influence of advisors with financial ties to the meat and dairy industries. Looking back at the original 1980 dietary guidelines, Dr. Kahn asks an important question: how much has really changed? His takeaway remains refreshingly simple—eat food, mostly plants, not too much. Short topics this week include...

info_outline
Episode 475: The Great Debate on Aspirin Dosing and the President show art Episode 475: The Great Debate on Aspirin Dosing and the President

Heart Doc VIP with Dr. Joel Kahn

Dr. Kahn kicks off 2026 by reviewing recent media reports on aspirin use and dosing for the prevention of cardiovascular events in the President of the United States. Much of the coverage overlooks an important factor: the relationship between aspirin dose and body weight. Dr. Kahn examines data from multiple studies suggesting that, in some cases, only higher-dose aspirin was effective in preventing cardiovascular events. As always, listeners are encouraged to discuss aspirin use and dosing with their own medical team. Additional topics this week include the health impact of carryout meals,...

info_outline
Episode 474: Tim Kaufman on Beating Ehlers-Danlos Syndrome and Addiction with a Plant -Based Diet show art Episode 474: Tim Kaufman on Beating Ehlers-Danlos Syndrome and Addiction with a Plant -Based Diet

Heart Doc VIP with Dr. Joel Kahn

Tim Kaufman's journey is nothing short of remarkable. Diagnosed with Ehlers-Danlos Syndrome—an inherited condition affecting collagen that impacts the heart, joints, and tendons—Tim found himself in a dark place by 2011, struggling with food, alcohol, and painkiller addiction, compounded by morbid obesity. His inspiring recovery through a plant-based diet led him to complete the Lake Placid Ironman in 2024 while sustaining an incredible 200 lb weight loss. Tim shares his transformative story in his book . Learn more about his journey at .

info_outline
 
More Episodes

This week, Dr. Kahn dives into four new research papers on omega-3 fatty acids and their impact on heart and brain health. The discussion highlights several eye-opening findings, including reduced atrial fibrillation risk and improved cardiovascular outcomes in patients undergoing hemodialysis. Dr. Kahn also explains how omega-3 intake supports brain health and why the “right” dose depends on the specific condition being addressed. Food sources, fish oil, algae-based supplements, and ahiflower are compared as practical ways to reach optimal omega-3 levels. 

Additional topics in this episode include newly approved AI software for early detection of heart disease, the role of statins in patients with type 2 diabetes, the science—and hype—around NAD+ boosters, and emerging data on Prolon fasting for Crohn’s disease. Dr. Kahn also reviews concerning research on heart rhythm risks associated with high-intensity endurance exercise in athletes over the age of 50.

As always, the episode blends cutting-edge research with real-world clinical insight to help clarify what actually matters for long-term heart health.

Thanks to The Fresh Pressed Olive Oil Club — get a bottle for $1 at getfreshDRKAHN.com

More About This Episode

This episode takes a deeper look at why omega-3 blood levels matter more than simply taking a supplement. Dr. Kahn reviews large population studies linking higher omega-3 levels to lower risks of atrial fibrillation, early-onset dementia, and major cardiovascular events, including in high-risk groups such as patients on hemodialysis. The key takeaway: testing omega-3 status and personalizing intake may be far more effective than a one-size-fits-all approach. 

Beyond omega-3s, Dr. Kahn explores several timely and surprising topics, including AI-enhanced CT scan technology designed to detect silent heart disease without additional radiation, real-world data on statin benefits in patients with type 2 diabetes, and why costly NAD+ supplements may ultimately function as a form of vitamin B3. The episode also examines new evidence on fasting-mimicking diets for Crohn’s disease and potential heart rhythm risks in high-level endurance athletes over 50.

Throughout the discussion, Dr. Kahn emphasizes practical, evidence-based steps patients can review with their physicians, including omega-3 blood testing, coronary calcium scoring, and tailoring lifestyle and supplement strategies to individual risk factors.